Aerovate Therapeutics
Why Robinhood?
You can watch AVTE and buy or sell other stocks, ETFs, and their options commission-free!About AVTE
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
AVTE Key Statistics
Stock Snapshot
Aerovate Therapeutics(AVTE) stock is priced at $9.80, giving the company a market capitalization of 483.3M. It carries a P/E multiple of -2.43.
On 2026-03-31, Aerovate Therapeutics(AVTE) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Aerovate Therapeutics(AVTE) stock has reached 0, versus its average volume of 556.32K.
The stock's 52-week range extends from a low of $6.57 to a high of $100.10.
The stock's 52-week range extends from a low of $6.57 to a high of $100.10.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.